Moshe Shoham Sells 33,700 Shares of Microbot Medical Inc (MBOT) Stock
Microbot Medical Inc (NASDAQ:MBOT) Director Moshe Shoham sold 33,700 shares of the firm’s stock in a transaction on Monday, October 9th. The stock was sold at an average price of $1.50, for a total value of $50,550.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Microbot Medical Inc (NASDAQ MBOT) traded down 6.34% during midday trading on Tuesday, hitting $1.33. The stock had a trading volume of 1,850,890 shares. The stock’s market cap is $58.57 million. Microbot Medical Inc has a one year low of $1.00 and a one year high of $15.66. The firm has a 50 day moving average price of $1.15 and a 200 day moving average price of $2.53.
Microbot Medical (NASDAQ:MBOT) last posted its quarterly earnings results on Monday, August 14th. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.48) by $0.44. Equities analysts expect that Microbot Medical Inc will post ($25.02) EPS for the current year.
Microbot Medical Company Profile
Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.
Receive News & Ratings for Microbot Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.